| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
* From the Division d'Anesthésiologie,
Département APSIC, Hôpitaux Universitaires de Genève, Genève, Switzerland and Abteilung Chirurgie, Kreisspital Oberengadin, Samedan, Switzerland.
Address correspondence to: Dr. Martin R. Tramèr, Division of Anaesthesiology, Geneva University Hospitals, 24, Rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. Phone: 41-22-382-7403; Fax: 41-22-372-7690; E-mail: martin.tramer{at}hcuge.ch
Purpose: To estimate the efficacy and harm produced by droperidol in the prevention of postoperative nausea and vomiting (PONV).
Methods: Systematic search (MEDLINE, EMBASE, Cochrane library, hand-searching, bibliographies, all languages, up to May 1999) for randomised comparisons of droperidol with placebo in surgical patients. Relevant end points were prevention of early PONV (up to six hours postoperatively), and late PONV (24 hr), and adverse effects. Combined data were analysed using relative risk and NNT.
Results: In 76 trials, 5,351 patients received 24 different regimens of droperidol. The average incidence of early and late PONV in controls was 34% and 51%, respectively. Droperidol was more efficacious than placebo in preventing PONV. In adults, the anti-nausea effect was short-lived, and there was no dose-responsiveness; with 0.25 to 0.30 mg the number-needed-to-treat (NNT) to prevent early nausea was 5. For both early and late anti-vomiting efficacy there was dose-responsiveness; best efficacy was with 1.5 mg to 2.5 mg (NNT, 7). In children, there was dose-responsiveness; best efficacy was with 75 µg•kg–1 (NNT to prevent early and late vomiting, 4). Two children had extrapyramidal symptoms with droperidol (NNT in children, 91; in any patient, 408). There was dose-responsiveness for sedation and drowsiness (with 2.5 mg the NNT was 7.8). Droperidol prevented postoperative headache (NNT, –25).
Conclusions: Droperidol is anti-emetic in the surgical setting. The effect on nausea is short-lived but more pronounced than the effect on vomiting. Sedation and drowsiness are dose-dependent, extrapyramidal symptoms are rare, and there is a protective effect against headache.
This article has been cited by other articles:
 |
|
 |
|
  Y. L. Yang, H. Y. Lai, J. J. Wang, P. K. Wang, T. Y. Chen, C. C. Chu, and Y. Lee The timing of haloperidol administration does not affect its prophylactic antiemetic efficacy: [Le moment choisi pour l'administration d'haloperidol n'affecte pas son efficacite anti-emetique prophylactique] Can J Anesth, May 1, 2008; 55(5): 270 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Habib and T. J. Gan Haloperidol for Postoperative Nausea and Vomiting: Are We Reinventing the Wheel? Anesth. Analg., May 1, 2008; 106(5): 1343 - 1345. [Full Text] [PDF]
|
|
|
|
|
|
A. S. Habib and T. J. Gan PRO: The Food and Drug Administration Black Box Warning on Droperidol Is Not Justified Anesth. Analg., May 1, 2008; 106(5): 1414 - 1417. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Gan, T. A. Meyer, C. C. Apfel, F. Chung, P. J. Davis, A. S. Habib, V. D. Hooper, A. L. Kovac, P. Kranke, P. Myles, et al. Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting Anesth. Analg., December 1, 2007; 105(6): 1615 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iijima, T. Ishiyama, S. Kashimoto, T. Yamaguchi, T. Andoh, K. Hanawa, I. Tanzawa, K. Kawata, T. Hanawa, and Y. Hiejima A Comparison of Three Different Concentrations of Ropivacaine with Fentanyl for Patient-Controlled Epidural Analgesia Anesth. Analg., August 1, 2007; 105(2): 507 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Jackson, A. H. Sheehan, and J. G. Reddan Evidence-based review of the black-box warning for droperidol Am. J. Health Syst. Pharm., June 1, 2007; 64(11): 1174 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lee, P. K. Wang, H. Y. Lai, Y. L. Yang, C. C. Chu, and J. J. Wang Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting: [L'haloperidol est aussi efficace que l'ondansetron dans la prevention des nausees et vomissements postoperatoires] Can J Anesth, May 1, 2007; 54(5): 349 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M Wilhelm, M. L Dehoorne-Smith, and P. B Kale-Pradhan Prevention of Postoperative Nausea and Vomiting Ann. Pharmacother., January 1, 2007; 41(1): 68 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Golembiewski, E. Chernin, and T. Chopra Prevention and treatment of postoperative nausea and vomiting Am. J. Health Syst. Pharm., June 15, 2005; 62(12): 1247 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thompson and J. R. Balser Perioperative cardiac arrhythmias Br. J. Anaesth., July 1, 2004; 93(1): 86 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Turner, J. L. Parlow, N. D. Avery, D. A. Tod, and A. G. Day Prophylaxis of Postoperative Nausea and Vomiting with Oral, Long-Acting Dimenhydrinate in Gynecologic Outpatient Laparoscopy Anesth. Analg., June 1, 2004; 98(6): 1660 - 1664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, Z. Luo, and P. F. White A Model for Evaluating Droperidol's Effect on the Median QTc Interval Anesth. Analg., May 1, 2004; 98(5): 1330 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Habib, H. E. El-Moalem, and T. J. Gan The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials: [L'efficacite de la combinaison des antagonistes des recepteurs 5-HT3 et du droperidol ou de la dexame- thasone est similaire pour prevenir les NVPO. Une meta-analyse d'essais randomises et controles] Can J Anesth, April 1, 2004; 51(4): 311 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Habib and T. J. Gan Evidence-based management of postoperative nausea and vomiting: a review: [Le traitement des nausees et des vomissements postoperatoires fonde sur des donnees probantes : une revue] Can J Anesth, April 1, 2004; 51(4): 326 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lee, H.-Y. Lai, P.-C. Lin, Y.-S. Lin, S.-J. Huang, and M.-H. Shyr A Dose Ranging Study of Dexamethasone for Preventing Patient-Controlled Analgesia-Related Nausea and Vomiting: A Comparison of Droperidol with Saline Anesth. Analg., April 1, 2004; 98(4): 1066 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Parlow, I. Costache, N. Avery, and K. Turner Single-Dose Haloperidol for the Prophylaxis of Postoperative Nausea and Vomiting After Intrathecal Morphine Anesth. Analg., April 1, 2004; 98(4): 1072 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. von Elm, G. Poglia, B. Walder, and M. R. Tramer Different Patterns of Duplicate Publication: An Analysis of Articles Used in Systematic Reviews JAMA, February 25, 2004; 291(8): 974 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Shafer, A. S. Habib, and T. J. Gan Safety of Patients Reason for FDA Black Box Warning on Droperidol * Response Anesth. Analg., February 1, 2004; 98(2): 551 - 552. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Joris, N. J. Poth, A. M. Djamadar, D. I. Sessler, E. E. Hamoir, T. R. Defechereux, M. R. Meurisse, and M. L. Lamy Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy{dagger} Br. J. Anaesth., December 1, 2003; 91(6): 857 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dershwitz, A. S. Habib, and T. J. Gan There Should Be a Threshold Dose for the FDA Black-Box Warning on Droperidol * Response Anesth. Analg., November 1, 2003; 97(5): 1542 - 1543. [Full Text] [PDF]
|
|
|
|
|
|
X. Culebras, J.-B. Corpataux, G. Gaggero, and M. R. Tramer The Antiemetic Efficacy of Droperidol Added to Morphine Patient-Controlled Analgesia: A Randomized, Controlled, Multicenter Dose-Finding Study Anesth. Analg., September 1, 2003; 97(3): 816 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Gan, T. Meyer, C. C. Apfel, F. Chung, P. J. Davis, S. Eubanks, A. Kovac, B. K. Philip, D. I. Sessler, J. Temo, et al. Consensus Guidelines for Managing Postoperative Nausea and Vomiting Anesth. Analg., July 1, 2003; 97(1): 62 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Beattie Strategies to reduce postoperative nausea and vomiting: does metoclopramide have a role?/Reduction des nausees et vomissements postoperatoires : le metoclopramide y joue-t-il un role ? Can J Anesth, December 1, 2002; 49(10): 1009 - 1015. [Full Text] [PDF]
|
|
|
|
|
|
B. Ben-David, P. J. DeMeo, C. Lucyk, and D. Solosko Minidose Lidocaine-Fentanyl Spinal Anesthesia in Ambulatory Surgery: Prophylactic Nalbuphine Versus Nalbuphine Plus Droperidol Anesth. Analg., December 1, 2002; 95(6): 1596 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Freymond, J.-P. Mustaki, D. R. Spahn, and B. Jaques Droperidol-Treated PONV and Bilateral Mandibular Fracture After Maxillofacial Surgery Anesth. Analg., November 1, 2002; 95(5): 1465 - 1465. [Full Text] [PDF]
|
|
|
|
|
|
P. Kranke, A. M. Morin, N. Roewer, H. Wulf, and L. H. Eberhart The Efficacy and Safety of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting: A Quantitative Systematic Review Anesth. Analg., July 1, 2002; 95(1): 133 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wooltorton Droperidol: cardiovascular toxicity and deaths Can. Med. Assoc. J., April 1, 2002; 166(7): 932 - 932. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
